Catechin-Induced changes in PODXL, DNMTs, and miRNA expression in Nalm6 cells: an integrated in silico and in vitro approach

Bibliographic Details
Title: Catechin-Induced changes in PODXL, DNMTs, and miRNA expression in Nalm6 cells: an integrated in silico and in vitro approach
Authors: Ali Afgar, Alireza Keyhani, Amirreza Afgar, Mohamad Javad Mirzaei-Parsa, Mahdiyeh Ramezani Zadeh Kermani, Masoud Rezaei, Mohammad Ebrahimipour, Ladan Langroudi, Mahla Sattarzadeh Bardsiri, Reza Vahidi
Source: BMC Complementary Medicine and Therapies, Vol 24, Iss 1, Pp 1-18 (2024)
Publisher Information: BMC, 2024.
Publication Year: 2024
Collection: LCC:Other systems of medicine
Subject Terms: PODXL, Methyltransferase, miRNAs, Docking, MD simulation, ALL, Other systems of medicine, RZ201-999
More Details: Abstract Background This study explored the impact of predicted miRNAs on DNA methyltransferases (DNMTs) and the PODXL gene in Nalm6 cells, revealing the significance of these miRNAs in acute lymphocytic leukemia (ALL). Methods A comprehensive approach was adopted, integrating bioinformatic analyses encompassing protein structure prediction, molecular docking, dynamics, and ADMET profiling, in conjunction with evaluations of gene and miRNA expression patterns. This methodology was employed to elucidate the therapeutic potential of catechin compounds in modulating the activity of DNA methyltransferases (DNMTs) and the PODXL gene. Results The findings from our investigation indicate that catechins possess the capability to inhibit DNMT enzymes. This inhibitory effect is associated with the upregulation of microRNAs miR-200c and miR-548 and a concurrent downregulation of PODXL gene expression. These molecular interactions culminate in an augmented apoptotic response within ALL (Nalm6) cells. Conclusion The study posits that catechins may represent a viable therapeutic avenue for inducing apoptosis in ALL cells. This is achieved through the modulation of epigenetic mechanisms and alterations in gene expression profiles, highlighting the potential of catechins as agents for cancer therapy.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2662-7671
34011374
Relation: https://doaj.org/toc/2662-7671
DOI: 10.1186/s12906-024-04521-2
Access URL: https://doaj.org/article/1782fbecbd8945329f9e6eb340113746
Accession Number: edsdoj.1782fbecbd8945329f9e6eb340113746
Database: Directory of Open Access Journals
More Details
ISSN:26627671
34011374
DOI:10.1186/s12906-024-04521-2
Published in:BMC Complementary Medicine and Therapies
Language:English